fbpx

Brain Cancer

Cerebral Glioblastoma

Male, 48 years

Patient Internal 500182761

ICD-10 code

C71.8 Malignant Neoplasm of Overlapping Sites of Brain

Diagnosis (Incl. Metastases/Stage) and Year

May 2021
Cerebral Glioblastoma G4, IDH (-), TERT (+), Monosomy of Chromosome 10, EGFR1 amplification, MGMT (+), Ki67 – 20%. The patient is Post-Craniotomy with disease recurrence after 1 month.

Previous Treatment

Surgery, Radiation Therapy, Chemotherapy (Temozolomide and Lomustin)

Prognosis and Survival Expectation

The prognosis remains poor, with a median survival of 14 months from diagnosis.

Treatment Provided

Autologous DCV (8 doses) and CIK (4 doses) over a period of 10 months.

Patient Survival/Condition and Year
Date of Review: 15/10/2023

The patient has lived for 23 months after the diagnosis. It can be concluded that the addition of Immunotherapy, alongside Surgery, Chemotherapy and Radiation Therapy, has extended the patient’s survival by about 9 months from median survival.

Disclaimer

We encourage you to learn more about your condition and treatment options to make informed decisions about your healthcare. However, please keep in mind that not all information available online or in other sources is accurate or relevant to your specific situation. It’s important to rely on credible, evidence-based sources such as official medical websites, peer-reviewed publications, or information provided by professional healthcare organizations. Always discuss any information you find with your healthcare provider before making decisions, as they can help clarify details, address concerns, and ensure the information is appropriate for your unique needs.